Stoxx Europe 50
|
4 881,94
|
35,68
|
0,74 %
|
Analysen zu Stoxx Europe 50-Werten
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Sell | UBS AG | |
| 31.01.24 | Diageo Outperform | Bernstein Research | |
| 31.01.24 | Diageo Sell | Deutsche Bank AG | |
| 31.01.24 | BBVA Buy | Deutsche Bank AG | |
| 31.01.24 | L'Oréal Sell | Deutsche Bank AG | |
| 31.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 31.01.24 | Santander Neutral | JP Morgan Chase & Co. | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 31.01.24 | Diageo Hold | Jefferies & Company Inc. | |
| 30.01.24 | BBVA Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | Sanofi Buy | UBS AG | |
| 30.01.24 | Roche Neutral | UBS AG | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 30.01.24 | GSK Buy | UBS AG | |
| 30.01.24 | Diageo Overweight | Barclays Capital | |
| 30.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.01.24 | Diageo Sell | UBS AG | |
| 30.01.24 | Diageo Outperform | Bernstein Research | |
| 30.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.01.24 | Roche Sell | Deutsche Bank AG | |
| 30.01.24 | ASML NV Outperform | Bernstein Research | |
| 30.01.24 | Diageo Underperform | RBC Capital Markets | |
| 30.01.24 | Diageo Sell | UBS AG | |
| 30.01.24 | BBVA Buy | UBS AG | |
| 30.01.24 | BAT Neutral | UBS AG | |
| 30.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | BBVA Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.01.24 | ASML NV Buy | Deutsche Bank AG | |
| 30.01.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 30.01.24 | BBVA Outperform | RBC Capital Markets | |
| 30.01.24 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 29.01.24 | EssilorLuxottica Neutral | UBS AG | |
| 29.01.24 | Shell Outperform | RBC Capital Markets | |
| 29.01.24 | BAT Neutral | UBS AG | |
| 29.01.24 | Iberdrola Buy | UBS AG | |
| 29.01.24 | Enel Buy | UBS AG | |
| 29.01.24 | RELX Equal Weight | Barclays Capital | |
| 29.01.24 | UniCredit Overweight | JP Morgan Chase & Co. |